Dynamics of SARS-CoV-2-Spike-reactive antibody and T-cell responses in chronic kidney disease patients within 3 months after COVID-19 full vaccination.

Nayara PanizoEliseo AlbertElena Giménez-CiveraMaria Jesús PuchadesLuis D' MarcoLorena Gandía-SalmerónEstela GiménezIgnacio TorreAsunción SanchoEva GavelaMiguel Gonzalez-RicoMarco MontomoliCarmen Maria Perez-BaylachBegoña BonillaCamila SolanoMª Fernanda AlvaradoIsidro TorregrosaMaría Jesús AlcarazJose Luis Gorriz TeruelDavid Navarro

Published in: Clinical kidney journal (2022)

Most HD, PD and ACKD patients develop SARS-CoV-2-S antibody responses comparable to that of healthy controls, in contrast to KT recipients. Antibody waning at 3M was faster in HD, PD and ACKD patients. No differences in SARS-CoV-2 T-cell immunity responses were noticed across study groups.

Keyphrases

sars cov
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
coronavirus disease
magnetic resonance imaging